These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7845889)
41. Baicalein 5,6,7-trimethyl ether, a flavonoid derivative, stimulates fatty acid beta-oxidation in skin fibroblasts of X-linked adrenoleukodystrophy. Morita M; Takahashi I; Kanai M; Okafuji F; Iwashima M; Hayashi T; Watanabe S; Hamazaki T; Shimozawa N; Suzuki Y; Furuya H; Yamada T; Imanaka T FEBS Lett; 2005 Jan; 579(2):409-14. PubMed ID: 15642351 [TBL] [Abstract][Full Text] [Related]
42. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy. Unterrainer G; Molzer B; Forss-Petter S; Berger J Hum Mol Genet; 2000 Nov; 9(18):2609-16. PubMed ID: 11063720 [TBL] [Abstract][Full Text] [Related]
43. Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy. Singh I; Pahan K; Khan M FEBS Lett; 1998 Apr; 426(3):342-6. PubMed ID: 9600263 [TBL] [Abstract][Full Text] [Related]
44. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders. Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527 [TBL] [Abstract][Full Text] [Related]
45. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy. Moser HW; Moser AE; Singh I; O'Neill BP Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872 [TBL] [Abstract][Full Text] [Related]
46. Adrenoleukodystrophy: the restoration of peroxisomal beta-oxidation by transfection of normal cDNA. Shinnoh N; Yamada T; Yoshimura T; Furuya H; Yoshida Y; Suzuki Y; Shimozawa N; Orii T; Kobayashi T Biochem Biophys Res Commun; 1995 May; 210(3):830-6. PubMed ID: 7763255 [TBL] [Abstract][Full Text] [Related]
47. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Singh I; Moser AE; Goldfischer S; Moser HW Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4203-7. PubMed ID: 6588384 [TBL] [Abstract][Full Text] [Related]
48. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on fatty acid oxidation in fibroblasts from patients with peroxisomal diseases. Suzuki Y; Shimozawa N; Yajima S; Yamaguchi S; Orii T; Hashimoto T Biochem Pharmacol; 1991 Feb; 41(3):453-6. PubMed ID: 1994902 [TBL] [Abstract][Full Text] [Related]
49. Adrenoleukodystrophy: impaired oxidation of long chain fatty acids in cultured skin fibroblasts an adrenal cortex. Singh I; Moser HW; Moser AB; Kishimoto Y Biochem Biophys Res Commun; 1981 Oct; 102(4):1223-9. PubMed ID: 6797420 [No Abstract] [Full Text] [Related]
50. [Prenatal diagnosis of X-linked adrenoleukodystrophy]. Bao XH; Ping LL; Wang AH; Pan H; Wu Y; Xiong H; Zhang YH; Shi CY; Qin J; Wu X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):1-5. PubMed ID: 17285533 [TBL] [Abstract][Full Text] [Related]
51. Neonatal seizures and retardation in a girl with biochemical features of X-linked adrenoleukodystrophy: a possible new peroxisomal disease entity. Naidu S; Hoefler G; Watkins PA; Chen WW; Moser AB; Hoefler S; Rance NE; Powers JM; Beard M; Green WR Neurology; 1988 Jul; 38(7):1100-7. PubMed ID: 3386829 [TBL] [Abstract][Full Text] [Related]
52. [X-chromosomal adrenoleukodystrophy. A peroxisomal disease important for differential diagnosis in the internal medicine-neurological field]. Wagdi P; Meier C Schweiz Med Wochenschr; 1990 Sep; 120(35):1247-52. PubMed ID: 2218446 [TBL] [Abstract][Full Text] [Related]
53. Characterization of X-linked adrenoleukodystrophy in different biological specimens from ten Portuguese families. Jorge P; Quelhas D; Nogueira A J Inherit Metab Dis; 1993; 16(1):55-62. PubMed ID: 8387613 [TBL] [Abstract][Full Text] [Related]
54. Metabolism of branched chain fatty acids in peroxisomal disorders. Singh H; Usher S; Johnson D; Poulos A J Inherit Metab Dis; 1990; 13(3):387-9. PubMed ID: 1700192 [No Abstract] [Full Text] [Related]
55. The inborn errors of peroxisomal beta-oxidation: a review. Wanders RJ; van Roermund CW; Schutgens RB; Barth PG; Heymans HS; van den Bosch H; Tager JM J Inherit Metab Dis; 1990; 13(1):4-36. PubMed ID: 2109148 [TBL] [Abstract][Full Text] [Related]
56. Photosensitized killing of cultured fibroblasts from patients with peroxisomal disorders due to pyrene fatty acid-mediated ultraviolet damage. Hoefler G; Paschke E; Hoefler S; Moser AB; Moser HW J Clin Invest; 1991 Dec; 88(6):1873-9. PubMed ID: 1752949 [TBL] [Abstract][Full Text] [Related]
57. Molecular analysis of peroxisomal beta-oxidation enzymes in infants with peroxisomal disorders indicates heterogeneity of the primary defect. Guerroui S; Aubourg P; Chen WW; Hashimoto T; Scotto J Biochem Biophys Res Commun; 1989 May; 161(1):242-51. PubMed ID: 2471528 [TBL] [Abstract][Full Text] [Related]
58. Prenatal diagnosis of adrenoleukodystrophy by means of mutation analysis. Imamura A; Suzuki Y; Song XQ; Fukao T; Shimozawa N; Orii T; Kondo N Prenat Diagn; 1996 Mar; 16(3):259-61. PubMed ID: 8710781 [TBL] [Abstract][Full Text] [Related]
59. Very-long-chain polyunsaturated fatty acids accumulate in phosphatidylcholine of fibroblasts from patients with Zellweger syndrome and acyl-CoA oxidase1 deficiency. Abe Y; Honsho M; Nakanishi H; Taguchi R; Fujiki Y Biochim Biophys Acta; 2014 Apr; 1841(4):610-9. PubMed ID: 24418004 [TBL] [Abstract][Full Text] [Related]
60. Peroxisome disorders and cutaneous manifestations. Saurat JH; Itin P Dermatology; 1994; 188(1):1-2. PubMed ID: 8305747 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]